FCGR3A and neoplasm: Reduced core fucosylation of antibodies has been shown to increase IgG1 Fc binding affinity to the CD16a present on immune effector cells (especially NK cells and macrophages) [16], to increase ADCC/ADCP [17,18] and to enhance tumor inhibition in vivo [43,44].